| A | B | C | D | E | F | G | H | I | J | K | L | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | TASK_KEY | TASK_DESC | SCTID | FSN | CONCEPT_TYPE | SEVERITY | ACTION_TYPE | DefnStatus | TemplateMatched | IsComplex | IsOrphanet | Template Diagnostic |
2 | MAIN-1 | MisalignedConcepts: 1 | 442319005 | Folic acid prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 63718003 |Folic acid (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 87708000 |Vitamin (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
3 | MAIN-1 | MisalignedConcepts: 1 | 704139007 | Intravenous bisphosphonate prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^{ [I1] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } A{ [I2] 363701004 |Direct substance (attribute)| -> 372907000 |Bisphosphonate (substance)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)|, [I2] 405814001 |Procedure site - Indirect (attribute)| -> 29092000 |Venous structure (body structure)|, [I2] 410675002 |Route of administration (attribute)| -> 47625008 |Intravenous route (qualifier value)| } | ||
4 | MAIN-1 | MisalignedConcepts: 1 | 315054007 | Angiotensin converting enzyme inhibitor prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372733002 |Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
5 | MAIN-1 | MisalignedConcepts: 1 | 699041005 | Warfarin prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^{ [I1] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } A{ [I2] 363701004 |Direct substance (attribute)| -> 372756006 |Warfarin (substance)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
6 | MAIN-1 | MisalignedConcepts: 1 | 420965003 | Antineoplastic agent prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372688009 |Antineoplastic agent (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
7 | MAIN-1 | MisalignedConcepts: 1 | 421728001 | Anticoagulant prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372862008 |Anticoagulant (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
8 | MAIN-1 | MisalignedConcepts: 1 | 315053001 | Statin prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372912004 |Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
9 | MAIN-1 | MisalignedConcepts: 1 | 392129008 | Low dose heparin prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | P | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372877000 |Heparin (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
10 | MAIN-1 | MisalignedConcepts: 1 | 700108001 | Bisphosphonate prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^{ [I1] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } A{ [I2] 363701004 |Direct substance (attribute)| -> 372907000 |Bisphosphonate (substance)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
11 | MAIN-1 | MisalignedConcepts: 1 | 266715005 | Steroid prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } A{ [I3] 363701004 |Direct substance (attribute)| -> 116566001 |Steroid (substance)| } | ||
12 | MAIN-2 | MisalignedConcepts: 2 | 408491002 | Calcium channel blocker prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 373304005 |Substance with calcium channel blocker mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
13 | MAIN-2 | MisalignedConcepts: 2 | 407665006 | Digoxin prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 387461009 |Digoxin (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
14 | MAIN-2 | MisalignedConcepts: 2 | 407636000 | Spironolactone prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 387078006 |Spironolactone (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 372695000 |Diuretic (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
15 | MAIN-2 | MisalignedConcepts: 2 | 1680000 | Secondary chemoprophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | P | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^A{ [I1] 363701004 |Direct substance (attribute)| -> 372688009 |Antineoplastic agent (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
16 | MAIN-2 | MisalignedConcepts: 2 | 704153007 | Histamine H2 receptor antagonist prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^{ [I1] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } A{ [I2] 363701004 |Direct substance (attribute)| -> 372524001 |Substance with histamine H2 receptor antagonist mechanism of action (substance)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
17 | MAIN-2 | MisalignedConcepts: 2 | 182935008 | Prophylactic iron therapy (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 71482002 |Iron compound (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
18 | MAIN-2 | MisalignedConcepts: 2 | 33762001 | Primary chemoprophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | P | N | N | Cardinality mismatch: N/A Relationship Group mismatches: ^A{ [I1] 363701004 |Direct substance (attribute)| -> 372688009 |Antineoplastic agent (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
19 | MAIN-2 | MisalignedConcepts: 2 | 408488002 | Glyceryl trinitrate prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 387404004 |Glyceryl trinitrate (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
20 | MAIN-2 | MisalignedConcepts: 2 | 275922000 | Pregnancy vitamin/iron prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | P | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 71482002 |Iron compound (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 87708000 |Vitamin (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
21 | MAIN-2 | MisalignedConcepts: 2 | 736388004 | Administration of intramuscular vitamin K prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: A 0 found != [1..1] required. [[~1..1]] { [[~1..1]] 260686004 = 129445006, [[~1..1]] 363701004 = [[+id( << 410942007 |Drug or medicament (substance)| ) @null]], [[~1..1]] 363703001 = 360271000 } Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 65183007 |Vitamin K and vitamin K derivative (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)|, [I1] 410675002 |Route of administration (attribute)| -> 78421000 |Intramuscular route (qualifier value)| } | ||
22 | MAIN-3 | MisalignedConcepts: 3 | 315052006 | Beta blocker prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 373254001 |Substance with beta adrenergic receptor antagonist mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
23 | MAIN-3 | MisalignedConcepts: 3 | 395010006 | Angiotensin II receptor antagonist prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 372913009 |Substance with angiotensin II receptor antagonist mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
24 | MAIN-3 | MisalignedConcepts: 3 | 420848008 | Antimalarial prophylaxis (procedure) | MEDIUM | VALIDATION_CHECK | SD | N | N | Cardinality mismatch: N/A Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 373287002 |Substance with antimalarial mechanism of action (substance)|, [I1] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } ^{ [I2] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I2] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I2] 260686004 |Method (attribute)| -> 129445006 |Administration - action (qualifier value)| } | ||
25 | MAIN-3 | MisalignedConcepts: 3 | 66260009 | Injection of prophylactic substance (procedure) | MEDIUM | VALIDATION_CHECK | P | N | N | Cardinality mismatch: A 0 found != [1..1] required. [[~1..1]] { [[~1..1]] 260686004 = 129445006, [[~1..1]] 363701004 = [[+id( << 410942007 |Drug or medicament (substance)| ) @null]], [[~1..1]] 363703001 = 360271000 } Relationship Group mismatches: A{ [I1] 363701004 |Direct substance (attribute)| -> 410942007 |Drug or medicament (substance)|, [I1] 363703001 |Has intent (attribute)| -> 360271000 |Prophylaxis - procedure intent (qualifier value)|, [I1] 260686004 |Method (attribute)| -> 129326001 |Injection - action (qualifier value)| } | ||
26 | ||||||||||||
27 | ||||||||||||
28 | ||||||||||||
29 | ||||||||||||
30 | ||||||||||||
31 | ||||||||||||
32 | ||||||||||||
33 | ||||||||||||
34 | ||||||||||||
35 | ||||||||||||
36 | ||||||||||||
37 | ||||||||||||
38 | ||||||||||||
39 | ||||||||||||
40 | ||||||||||||
41 | ||||||||||||
42 | ||||||||||||
43 | ||||||||||||
44 | ||||||||||||
45 | ||||||||||||
46 | ||||||||||||
47 | ||||||||||||
48 | ||||||||||||
49 | ||||||||||||
50 | ||||||||||||
51 | ||||||||||||
52 | ||||||||||||
53 | ||||||||||||
54 | ||||||||||||
55 | ||||||||||||
56 | ||||||||||||
57 | ||||||||||||
58 | ||||||||||||
59 | ||||||||||||
60 | ||||||||||||
61 | ||||||||||||
62 | ||||||||||||
63 | ||||||||||||
64 | ||||||||||||
65 | ||||||||||||
66 | ||||||||||||
67 | ||||||||||||
68 | ||||||||||||
69 | ||||||||||||
70 | ||||||||||||
71 | ||||||||||||
72 | ||||||||||||
73 | ||||||||||||
74 | ||||||||||||
75 | ||||||||||||
76 | ||||||||||||
77 | ||||||||||||
78 | ||||||||||||
79 | ||||||||||||
80 | ||||||||||||
81 | ||||||||||||
82 | ||||||||||||
83 | ||||||||||||
84 | ||||||||||||
85 | ||||||||||||
86 | ||||||||||||
87 | ||||||||||||
88 | ||||||||||||
89 | ||||||||||||
90 | ||||||||||||
91 | ||||||||||||
92 | ||||||||||||
93 | ||||||||||||
94 | ||||||||||||
95 | ||||||||||||
96 | ||||||||||||
97 | ||||||||||||
98 | ||||||||||||
99 | ||||||||||||
100 |